Enterprise Value
152.3M
Cash
135.2M
Avg Qtr Burn
-18.62M
Short % of Float
0.24%
Insider Ownership
9.63%
Institutional Own.
73.74%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Phase 2 Data readout | ||
PHA121 Details Hereditary angioedema | Phase 2 Interim update | |
PHVS416 Details Hereditary angioedema | Phase 2 Update | |
PHVS719 Details Hereditary angioedema | Phase 1 Interim update |